Kim Dong 4
4 · UroGen Pharma Ltd. · Filed Feb 2, 2024
Insider Transaction Report
Form 4
Kim Dong
Chief Financial Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2024-01-31+3,333→ 26,585 total - Exercise/Conversion
Restricted Stock Units
2024-01-31−3,333→ 6,667 total→ Ordinary Shares (3,333 underlying) - Award
Restricted Stock Units
2024-01-31+12,000→ 12,000 total→ Ordinary Shares (12,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F2]The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024.
- [F3]1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027.